The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Orally Disintegrating Tablet Market Insights and Forecast to 2028
Synopsis
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
Market Analysis and Insights: Global Orally Disintegrating Tablet Market
Due to the COVID-19 pandemic, the global Orally Disintegrating Tablet market size is estimated to be worth US$ 15650 million in 2022 and is forecast to a readjusted size of US$ 30400 million by 2028 with a CAGR of 11.7% during the review period. Fully considering the economic change by this health crisis, Anti-Psychotics Drug accounting for % of the Orally Disintegrating Tablet global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While CNS Diseases segment is altered to an % CAGR throughout this forecast period.
Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market. North America is the largest market of glass packaging, holding a share more than 40%. As for the types of products, it can be divided into anti-psychotics drug, anti-epileptics drug and others. As for the applications of products, it is widely used in CNS diseases, gastrointestinal diseases, CVS diseases and others. The most common application is in CNS diseases packaging, with a share about 55%.
Global Orally Disintegrating Tablet Scope and Segment
Orally Disintegrating Tablet market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Orally Disintegrating Tablet market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Others
By Company
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
Market Analysis and Insights: Global Orally Disintegrating Tablet Market
Due to the COVID-19 pandemic, the global Orally Disintegrating Tablet market size is estimated to be worth US$ 15650 million in 2022 and is forecast to a readjusted size of US$ 30400 million by 2028 with a CAGR of 11.7% during the review period. Fully considering the economic change by this health crisis, Anti-Psychotics Drug accounting for % of the Orally Disintegrating Tablet global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While CNS Diseases segment is altered to an % CAGR throughout this forecast period.
Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market. North America is the largest market of glass packaging, holding a share more than 40%. As for the types of products, it can be divided into anti-psychotics drug, anti-epileptics drug and others. As for the applications of products, it is widely used in CNS diseases, gastrointestinal diseases, CVS diseases and others. The most common application is in CNS diseases packaging, with a share about 55%.
Global Orally Disintegrating Tablet Scope and Segment
Orally Disintegrating Tablet market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Orally Disintegrating Tablet market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Others
By Company
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Index1 Study Coverage
1.1 Orally Disintegrating Tablet Product Introduction
1.2 Market by Type
1.2.1 Global Orally Disintegrating Tablet Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Orally Disintegrating Tablet Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Orally Disintegrating Tablet Sales Estimates and Forecasts 2017-2028
2.2 Global Orally Disintegrating Tablet Revenue Estimates and Forecasts 2017-2028
2.3 Global Orally Disintegrating Tablet Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Orally Disintegrating Tablet Sales by Region
2.4.1 Global Orally Disintegrating Tablet Sales by Region (2017-2022)
2.4.2 Global Sales Orally Disintegrating Tablet by Region (2023-2028)
2.5 Global Orally Disintegrating Tablet Revenue by Region
2.5.1 Global Orally Disintegrating Tablet Revenue by Region (2017-2022)
2.5.2 Global Orally Disintegrating Tablet Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Orally Disintegrating Tablet Sales by Manufacturers
3.1.1 Global Top Orally Disintegrating Tablet Manufacturers by Sales (2017-2022)
3.1.2 Global Orally Disintegrating Tablet Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Orally Disintegrating Tablet in 2021
3.2 Global Orally Disintegrating Tablet Revenue by Manufacturers
3.2.1 Global Orally Disintegrating Tablet Revenue by Manufacturers (2017-2022)
3.2.2 Global Orally Disintegrating Tablet Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Orally Disintegrating Tablet Revenue in 2021
3.3 Global Orally Disintegrating Tablet Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Orally Disintegrating Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Orally Disintegrating Tablet Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Orally Disintegrating Tablet Sales by Type
4.1.1 Global Orally Disintegrating Tablet Historical Sales by Type (2017-2022)
4.1.2 Global Orally Disintegrating Tablet Forecasted Sales by Type (2023-2028)
4.1.3 Global Orally Disintegrating Tablet Sales Market Share by Type (2017-2028)
4.2 Global Orally Disintegrating Tablet Revenue by Type
4.2.1 Global Orally Disintegrating Tablet Historical Revenue by Type (2017-2022)
4.2.2 Global Orally Disintegrating Tablet Forecasted Revenue by Type (2023-2028)
4.2.3 Global Orally Disintegrating Tablet Revenue Market Share by Type (2017-2028)
4.3 Global Orally Disintegrating Tablet Price by Type
4.3.1 Global Orally Disintegrating Tablet Price by Type (2017-2022)
4.3.2 Global Orally Disintegrating Tablet Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Orally Disintegrating Tablet Sales by Application
5.1.1 Global Orally Disintegrating Tablet Historical Sales by Application (2017-2022)
5.1.2 Global Orally Disintegrating Tablet Forecasted Sales by Application (2023-2028)
5.1.3 Global Orally Disintegrating Tablet Sales Market Share by Application (2017-2028)
5.2 Global Orally Disintegrating Tablet Revenue by Application
5.2.1 Global Orally Disintegrating Tablet Historical Revenue by Application (2017-2022)
5.2.2 Global Orally Disintegrating Tablet Forecasted Revenue by Application (2023-2028)
5.2.3 Global Orally Disintegrating Tablet Revenue Market Share by Application (2017-2028)
5.3 Global Orally Disintegrating Tablet Price by Application
5.3.1 Global Orally Disintegrating Tablet Price by Application (2017-2022)
5.3.2 Global Orally Disintegrating Tablet Price Forecast by Application (2023-2028)
6 North America
6.1 North America Orally Disintegrating Tablet Market Size by Type
6.1.1 North America Orally Disintegrating Tablet Sales by Type (2017-2028)
6.1.2 North America Orally Disintegrating Tablet Revenue by Type (2017-2028)
6.2 North America Orally Disintegrating Tablet Market Size by Application
6.2.1 North America Orally Disintegrating Tablet Sales by Application (2017-2028)
6.2.2 North America Orally Disintegrating Tablet Revenue by Application (2017-2028)
6.3 North America Orally Disintegrating Tablet Market Size by Country
6.3.1 North America Orally Disintegrating Tablet Sales by Country (2017-2028)
6.3.2 North America Orally Disintegrating Tablet Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Orally Disintegrating Tablet Market Size by Type
7.1.1 Europe Orally Disintegrating Tablet Sales by Type (2017-2028)
7.1.2 Europe Orally Disintegrating Tablet Revenue by Type (2017-2028)
7.2 Europe Orally Disintegrating Tablet Market Size by Application
7.2.1 Europe Orally Disintegrating Tablet Sales by Application (2017-2028)
7.2.2 Europe Orally Disintegrating Tablet Revenue by Application (2017-2028)
7.3 Europe Orally Disintegrating Tablet Market Size by Country
7.3.1 Europe Orally Disintegrating Tablet Sales by Country (2017-2028)
7.3.2 Europe Orally Disintegrating Tablet Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Orally Disintegrating Tablet Market Size by Type
8.1.1 Asia Pacific Orally Disintegrating Tablet Sales by Type (2017-2028)
8.1.2 Asia Pacific Orally Disintegrating Tablet Revenue by Type (2017-2028)
8.2 Asia Pacific Orally Disintegrating Tablet Market Size by Application
8.2.1 Asia Pacific Orally Disintegrating Tablet Sales by Application (2017-2028)
8.2.2 Asia Pacific Orally Disintegrating Tablet Revenue by Application (2017-2028)
8.3 Asia Pacific Orally Disintegrating Tablet Market Size by Region
8.3.1 Asia Pacific Orally Disintegrating Tablet Sales by Region (2017-2028)
8.3.2 Asia Pacific Orally Disintegrating Tablet Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Orally Disintegrating Tablet Market Size by Type
9.1.1 Latin America Orally Disintegrating Tablet Sales by Type (2017-2028)
9.1.2 Latin America Orally Disintegrating Tablet Revenue by Type (2017-2028)
9.2 Latin America Orally Disintegrating Tablet Market Size by Application
9.2.1 Latin America Orally Disintegrating Tablet Sales by Application (2017-2028)
9.2.2 Latin America Orally Disintegrating Tablet Revenue by Application (2017-2028)
9.3 Latin America Orally Disintegrating Tablet Market Size by Country
9.3.1 Latin America Orally Disintegrating Tablet Sales by Country (2017-2028)
9.3.2 Latin America Orally Disintegrating Tablet Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Orally Disintegrating Tablet Market Size by Type
10.1.1 Middle East and Africa Orally Disintegrating Tablet Sales by Type (2017-2028)
10.1.2 Middle East and Africa Orally Disintegrating Tablet Revenue by Type (2017-2028)
10.2 Middle East and Africa Orally Disintegrating Tablet Market Size by Application
10.2.1 Middle East and Africa Orally Disintegrating Tablet Sales by Application (2017-2028)
10.2.2 Middle East and Africa Orally Disintegrating Tablet Revenue by Application (2017-2028)
10.3 Middle East and Africa Orally Disintegrating Tablet Market Size by Country
10.3.1 Middle East and Africa Orally Disintegrating Tablet Sales by Country (2017-2028)
10.3.2 Middle East and Africa Orally Disintegrating Tablet Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Teva
11.1.1 Teva Corporation Information
11.1.2 Teva Overview
11.1.3 Teva Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Teva Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Mylan
11.3.1 Mylan Corporation Information
11.3.2 Mylan Overview
11.3.3 Mylan Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mylan Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Johnson and Johnson
11.5.1 Johnson and Johnson Corporation Information
11.5.2 Johnson and Johnson Overview
11.5.3 Johnson and Johnson Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson and Johnson Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson and Johnson Recent Developments
11.6 GSK
11.6.1 GSK Corporation Information
11.6.2 GSK Overview
11.6.3 GSK Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GSK Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GSK Recent Developments
11.7 Otsuka
11.7.1 Otsuka Corporation Information
11.7.2 Otsuka Overview
11.7.3 Otsuka Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Otsuka Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Otsuka Recent Developments
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Corporation Information
11.8.2 Eli Lilly and Company Overview
11.8.3 Eli Lilly and Company Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Eli Lilly and Company Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Eli Lilly and Company Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Corporation Information
11.9.2 AstraZeneca Overview
11.9.3 AstraZeneca Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 AstraZeneca Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 AstraZeneca Recent Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Corporation Information
11.10.2 Bristol-Myers Squibb Overview
11.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Bristol-Myers Squibb Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bristol-Myers Squibb Recent Developments
11.11 Conquer
11.11.1 Conquer Corporation Information
11.11.2 Conquer Overview
11.11.3 Conquer Orally Disintegrating Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Conquer Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Conquer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Orally Disintegrating Tablet Industry Chain Analysis
12.2 Orally Disintegrating Tablet Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Orally Disintegrating Tablet Production Mode & Process
12.4 Orally Disintegrating Tablet Sales and Marketing
12.4.1 Orally Disintegrating Tablet Sales Channels
12.4.2 Orally Disintegrating Tablet Distributors
12.5 Orally Disintegrating Tablet Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Orally Disintegrating Tablet Industry Trends
13.2 Orally Disintegrating Tablet Market Drivers
13.3 Orally Disintegrating Tablet Market Challenges
13.4 Orally Disintegrating Tablet Market Restraints
14 Key Findings in The Global Orally Disintegrating Tablet Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Orally Disintegrating Tablet Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Anti-Psychotics Drug
Table 3. Major Manufacturers of Anti-Epileptics Drug
Table 4. Major Manufacturers of Others
Table 5. Global Orally Disintegrating Tablet Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Orally Disintegrating Tablet Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Orally Disintegrating Tablet Sales by Region (2017-2022) & (M Units)
Table 8. Global Orally Disintegrating Tablet Sales Market Share by Region (2017-2022)
Table 9. Global Orally Disintegrating Tablet Sales by Region (2023-2028) & (M Units)
Table 10. Global Orally Disintegrating Tablet Sales Market Share by Region (2023-2028)
Table 11. Global Orally Disintegrating Tablet Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Orally Disintegrating Tablet Revenue Market Share by Region (2017-2022)
Table 13. Global Orally Disintegrating Tablet Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Orally Disintegrating Tablet Revenue Market Share by Region (2023-2028)
Table 15. Global Orally Disintegrating Tablet Sales by Manufacturers (2017-2022) & (M Units)
Table 16. Global Orally Disintegrating Tablet Sales Share by Manufacturers (2017-2022)
Table 17. Global Orally Disintegrating Tablet Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Orally Disintegrating Tablet Revenue Share by Manufacturers (2017-2022)
Table 19. Orally Disintegrating Tablet Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Orally Disintegrating Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Orally Disintegrating Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet as of 2021)
Table 22. Orally Disintegrating Tablet Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Orally Disintegrating Tablet Product Offered
Table 24. Date of Manufacturers Enter into Orally Disintegrating Tablet Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Orally Disintegrating Tablet Sales by Type (2017-2022) & (M Units)
Table 27. Global Orally Disintegrating Tablet Sales by Type (2023-2028) & (M Units)
Table 28. Global Orally Disintegrating Tablet Sales Share by Type (2017-2022)
Table 29. Global Orally Disintegrating Tablet Sales Share by Type (2023-2028)
Table 30. Global Orally Disintegrating Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Orally Disintegrating Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Orally Disintegrating Tablet Revenue Share by Type (2017-2022)
Table 33. Global Orally Disintegrating Tablet Revenue Share by Type (2023-2028)
Table 34. Orally Disintegrating Tablet Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Orally Disintegrating Tablet Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Orally Disintegrating Tablet Sales by Application (2017-2022) & (M Units)
Table 37. Global Orally Disintegrating Tablet Sales by Application (2023-2028) & (M Units)
Table 38. Global Orally Disintegrating Tablet Sales Share by Application (2017-2022)
Table 39. Global Orally Disintegrating Tablet Sales Share by Application (2023-2028)
Table 40. Global Orally Disintegrating Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Orally Disintegrating Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Orally Disintegrating Tablet Revenue Share by Application (2017-2022)
Table 43. Global Orally Disintegrating Tablet Revenue Share by Application (2023-2028)
Table 44. Orally Disintegrating Tablet Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Orally Disintegrating Tablet Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Orally Disintegrating Tablet Sales by Type (2017-2022) & (M Units)
Table 47. North America Orally Disintegrating Tablet Sales by Type (2023-2028) & (M Units)
Table 48. North America Orally Disintegrating Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Orally Disintegrating Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Orally Disintegrating Tablet Sales by Application (2017-2022) & (M Units)
Table 51. North America Orally Disintegrating Tablet Sales by Application (2023-2028) & (M Units)
Table 52. North America Orally Disintegrating Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Orally Disintegrating Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Orally Disintegrating Tablet Sales by Country (2017-2022) & (M Units)
Table 55. North America Orally Disintegrating Tablet Sales by Country (2023-2028) & (M Units)
Table 56. North America Orally Disintegrating Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Orally Disintegrating Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Orally Disintegrating Tablet Sales by Type (2017-2022) & (M Units)
Table 59. Europe Orally Disintegrating Tablet Sales by Type (2023-2028) & (M Units)
Table 60. Europe Orally Disintegrating Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Orally Disintegrating Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Orally Disintegrating Tablet Sales by Application (2017-2022) & (M Units)
Table 63. Europe Orally Disintegrating Tablet Sales by Application (2023-2028) & (M Units)
Table 64. Europe Orally Disintegrating Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Orally Disintegrating Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Orally Disintegrating Tablet Sales by Country (2017-2022) & (M Units)
Table 67. Europe Orally Disintegrating Tablet Sales by Country (2023-2028) & (M Units)
Table 68. Europe Orally Disintegrating Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Orally Disintegrating Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Orally Disintegrating Tablet Sales by Type (2017-2022) & (M Units)
Table 71. Asia Pacific Orally Disintegrating Tablet Sales by Type (2023-2028) & (M Units)
Table 72. Asia Pacific Orally Disintegrating Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Orally Disintegrating Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Orally Disintegrating Tablet Sales by Application (2017-2022) & (M Units)
Table 75. Asia Pacific Orally Disintegrating Tablet Sales by Application (2023-2028) & (M Units)
Table 76. Asia Pacific Orally Disintegrating Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Orally Disintegrating Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Orally Disintegrating Tablet Sales by Region (2017-2022) & (M Units)
Table 79. Asia Pacific Orally Disintegrating Tablet Sales by Region (2023-2028) & (M Units)
Table 80. Asia Pacific Orally Disintegrating Tablet Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Orally Disintegrating Tablet Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Orally Disintegrating Tablet Sales by Type (2017-2022) & (M Units)
Table 83. Latin America Orally Disintegrating Tablet Sales by Type (2023-2028) & (M Units)
Table 84. Latin America Orally Disintegrating Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Orally Disintegrating Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Orally Disintegrating Tablet Sales by Application (2017-2022) & (M Units)
Table 87. Latin America Orally Disintegrating Tablet Sales by Application (2023-2028) & (M Units)
Table 88. Latin America Orally Disintegrating Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Orally Disintegrating Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Orally Disintegrating Tablet Sales by Country (2017-2022) & (M Units)
Table 91. Latin America Orally Disintegrating Tablet Sales by Country (2023-2028) & (M Units)
Table 92. Latin America Orally Disintegrating Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Orally Disintegrating Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Orally Disintegrating Tablet Sales by Type (2017-2022) & (M Units)
Table 95. Middle East and Africa Orally Disintegrating Tablet Sales by Type (2023-2028) & (M Units)
Table 96. Middle East and Africa Orally Disintegrating Tablet Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Orally Disintegrating Tablet Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Orally Disintegrating Tablet Sales by Application (2017-2022) & (M Units)
Table 99. Middle East and Africa Orally Disintegrating Tablet Sales by Application (2023-2028) & (M Units)
Table 100. Middle East and Africa Orally Disintegrating Tablet Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Orally Disintegrating Tablet Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Orally Disintegrating Tablet Sales by Country (2017-2022) & (M Units)
Table 103. Middle East and Africa Orally Disintegrating Tablet Sales by Country (2023-2028) & (M Units)
Table 104. Middle East and Africa Orally Disintegrating Tablet Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Orally Disintegrating Tablet Revenue by Country (2023-2028) & (US$ Million)
Table 106. Teva Corporation Information
Table 107. Teva Description and Major Businesses
Table 108. Teva Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Teva Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Teva Recent Developments
Table 111. Merck Corporation Information
Table 112. Merck Description and Major Businesses
Table 113. Merck Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Merck Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Merck Recent Developments
Table 116. Mylan Corporation Information
Table 117. Mylan Description and Major Businesses
Table 118. Mylan Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Mylan Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Mylan Recent Developments
Table 121. Pfizer Corporation Information
Table 122. Pfizer Description and Major Businesses
Table 123. Pfizer Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Pfizer Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Pfizer Recent Developments
Table 126. Johnson and Johnson Corporation Information
Table 127. Johnson and Johnson Description and Major Businesses
Table 128. Johnson and Johnson Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Johnson and Johnson Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Johnson and Johnson Recent Developments
Table 131. GSK Corporation Information
Table 132. GSK Description and Major Businesses
Table 133. GSK Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. GSK Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. GSK Recent Developments
Table 136. Otsuka Corporation Information
Table 137. Otsuka Description and Major Businesses
Table 138. Otsuka Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Otsuka Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Otsuka Recent Developments
Table 141. Eli Lilly and Company Corporation Information
Table 142. Eli Lilly and Company Description and Major Businesses
Table 143. Eli Lilly and Company Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Eli Lilly and Company Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Eli Lilly and Company Recent Developments
Table 146. AstraZeneca Corporation Information
Table 147. AstraZeneca Description and Major Businesses
Table 148. AstraZeneca Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. AstraZeneca Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. AstraZeneca Recent Developments
Table 151. Bristol-Myers Squibb Corporation Information
Table 152. Bristol-Myers Squibb Description and Major Businesses
Table 153. Bristol-Myers Squibb Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Bristol-Myers Squibb Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Bristol-Myers Squibb Recent Developments
Table 156. Conquer Corporation Information
Table 157. Conquer Description and Major Businesses
Table 158. Conquer Orally Disintegrating Tablet Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. Conquer Orally Disintegrating Tablet Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Conquer Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Orally Disintegrating Tablet Distributors List
Table 164. Orally Disintegrating Tablet Customers List
Table 165. Orally Disintegrating Tablet Market Trends
Table 166. Orally Disintegrating Tablet Market Drivers
Table 167. Orally Disintegrating Tablet Market Challenges
Table 168. Orally Disintegrating Tablet Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Orally Disintegrating Tablet Product Picture
Figure 3. Global Orally Disintegrating Tablet Market Share by Type in 2021 & 2028
Figure 3. Anti-Psychotics Drug Product Picture
Figure 4. Anti-Epileptics Drug Product Picture
Figure 5. Others Product Picture
Figure 6. Global Orally Disintegrating Tablet Market Share by Application in 2021 & 2028
Figure 7. CNS Diseases
Figure 8. Gastrointestinal Diseases
Figure 9. CVS Diseases
Figure 10. Others
Figure 11. Orally Disintegrating Tablet Report Years Considered
Figure 12. Global Orally Disintegrating Tablet Sales 2017-2028 (M Units)
Figure 13. Global Orally Disintegrating Tablet Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Orally Disintegrating Tablet Revenue 2017-2028 (US$ Million)
Figure 15. Global Orally Disintegrating Tablet Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Orally Disintegrating Tablet Sales Market Share by Region (2017-2022)
Figure 17. Global Orally Disintegrating Tablet Sales Market Share by Region (2023-2028)
Figure 18. North America Orally Disintegrating Tablet Sales YoY (2017-2028) & (M Units)
Figure 19. North America Orally Disintegrating Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Orally Disintegrating Tablet Sales YoY (2017-2028) & (M Units)
Figure 21. Europe Orally Disintegrating Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Orally Disintegrating Tablet Sales YoY (2017-2028) & (M Units)
Figure 23. Asia-Pacific Orally Disintegrating Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Orally Disintegrating Tablet Sales YoY (2017-2028) & (M Units)
Figure 25. Latin America Orally Disintegrating Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Orally Disintegrating Tablet Sales YoY (2017-2028) & (M Units)
Figure 27. Middle East & Africa Orally Disintegrating Tablet Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Orally Disintegrating Tablet Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Orally Disintegrating Tablet in the World: Market Share by Orally Disintegrating Tablet Revenue in 2021
Figure 30. Global Orally Disintegrating Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Orally Disintegrating Tablet Sales Market Share by Type (2017-2028)
Figure 32. Global Orally Disintegrating Tablet Revenue Market Share by Type (2017-2028)
Figure 33. Global Orally Disintegrating Tablet Sales Market Share by Application (2017-2028)
Figure 34. Global Orally Disintegrating Tablet Revenue Market Share by Application (2017-2028)
Figure 35. North America Orally Disintegrating Tablet Sales Market Share by Type (2017-2028)
Figure 36. North America Orally Disintegrating Tablet Revenue Market Share by Type (2017-2028)
Figure 37. North America Orally Disintegrating Tablet Sales Market Share by Application (2017-2028)
Figure 38. North America Orally Disintegrating Tablet Revenue Market Share by Application (2017-2028)
Figure 39. North America Orally Disintegrating Tablet Sales Share by Country (2017-2028)
Figure 40. North America Orally Disintegrating Tablet Revenue Share by Country (2017-2028)
Figure 41. United States Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Orally Disintegrating Tablet Sales Market Share by Type (2017-2028)
Figure 44. Europe Orally Disintegrating Tablet Revenue Market Share by Type (2017-2028)
Figure 45. Europe Orally Disintegrating Tablet Sales Market Share by Application (2017-2028)
Figure 46. Europe Orally Disintegrating Tablet Revenue Market Share by Application (2017-2028)
Figure 47. Europe Orally Disintegrating Tablet Sales Share by Country (2017-2028)
Figure 48. Europe Orally Disintegrating Tablet Revenue Share by Country (2017-2028)
Figure 49. Germany Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 50. France Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Orally Disintegrating Tablet Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Orally Disintegrating Tablet Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Orally Disintegrating Tablet Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Orally Disintegrating Tablet Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Orally Disintegrating Tablet Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Orally Disintegrating Tablet Revenue Share by Region (2017-2028)
Figure 60. China Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 63. India Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Orally Disintegrating Tablet Sales Market Share by Type (2017-2028)
Figure 71. Latin America Orally Disintegrating Tablet Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Orally Disintegrating Tablet Sales Market Share by Application (2017-2028)
Figure 73. Latin America Orally Disintegrating Tablet Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Orally Disintegrating Tablet Sales Share by Country (2017-2028)
Figure 75. Latin America Orally Disintegrating Tablet Revenue Share by Country (2017-2028)
Figure 76. Mexico Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Orally Disintegrating Tablet Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Orally Disintegrating Tablet Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Orally Disintegrating Tablet Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Orally Disintegrating Tablet Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Orally Disintegrating Tablet Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Orally Disintegrating Tablet Revenue Share by Country (2017-2028)
Figure 85. Turkey Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Orally Disintegrating Tablet Revenue (2017-2028) & (US$ Million)
Figure 88. Orally Disintegrating Tablet Value Chain
Figure 89. Orally Disintegrating Tablet Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
